Valuation: Thermo Fisher Scientific, Inc.

Market Cap 258B 231B 212B 192B 360B 24,470B 366B 2,532B 1,016B 12,872B 967B 947B 40,594B P/E 2026 *
35.7x
P/E 2027 * 30.7x
Enterprise Value 292B 261B 240B 218B 407B 27,680B 414B 2,864B 1,150B 14,561B 1,094B 1,071B 45,919B EV / Sales 2026 *
6.07x
EV / Sales 2027 * 5.68x
Free-Float
82.85%
Yield 2026 *
0.27%
Yield 2027 * 0.29%
1 day-1.72%
1 week+3.02%
Current month+3.25%
1 month+2.56%
3 months+20.91%
6 months+49.49%
Current year+20.29%
1 week 674.37
Extreme 674.37
711.85
1 month 635.32
Extreme 635.32
711.85
Current year 435.27
Extreme 435.27
711.85
1 year 435.27
Extreme 435.27
711.85
3 years 385.46
Extreme 385.46
711.85
5 years 385.46
Extreme 385.46
711.85
10 years 139.07
Extreme 139.07
711.85
Manager TitleAgeSince
Chief Executive Officer 58 2009-10-14
Director of Finance/CFO 46 2026-02-28
President 47 2026-02-28
Director TitleAgeSince
Director/Board Member 68 2006-11-08
Chairman 58 2020-02-25
Director/Board Member 65 2009-05-25
Date Insider Type Main position Quantity % Market Cap. Importance
9/26/26 Free

Director

46 0.0000%
9/26/26 Free

Director

56 0.0000%
9/26/26 Free

Director

46 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.72%+3.02%+24.84%+61.56% 262B
-2.00%+1.08%+8.51%+23.61% 167B
-3.73%-2.67%-19.64%+66.81% 156B
-1.66%-8.76%-58.15%-15.23% 61.87B
-2.57%+2.13%+11.27%+49.10% 54.44B
0.00%+2.71%-13.09%-6.48% 53.3B
-3.47%+0.56%+22.12%+70.16% 51.07B
+0.84%-2.97%+9.17%+65.13% 50.25B
-3.61%+1.57%+34.72%+89.05% 47.17B
-18.64%-12.40%+148.33%+116.07% 43.8B
Average -3.66%+2.28%+16.81%+51.98% 94.64B
Weighted average by Cap. -2.88%+2.68%+11.54%+50.72%

Financials

2026 *2027 *
Net sales 48B 42.99B 39.54B 35.83B 66.98B 4,558B 68.23B 472B 189B 2,398B 180B 176B 7,561B 50.53B 45.26B 41.63B 37.72B 70.5B 4,798B 71.82B 496B 199B 2,524B 190B 186B 7,959B
Net income 7.36B 6.59B 6.06B 5.49B 10.27B 699B 10.46B 72.3B 29.02B 368B 27.62B 27.03B 1,159B 8.36B 7.48B 6.88B 6.24B 11.66B 793B 11.88B 82.08B 32.95B 417B 31.36B 30.69B 1,316B
Net Debt 33.81B 30.28B 27.85B 25.24B 47.17B 3,210B 48.06B 332B 133B 1,689B 127B 124B 5,326B 29.07B 26.03B 23.95B 21.7B 40.56B 2,760B 41.32B 286B 115B 1,452B 109B 107B 4,579B
Projected Income Statement - Annual - Thermo Fisher Scientific, Inc.
Logo Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (73.2%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - scientific analysis equipments (16.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc.; - diagnostics equipment and products (10.1%). Net sales break down by source of revenue between sales of products (58.4%) and services (41.6%). Net sales break down geographically as follows: North America (52.5%), Europe (25.3%), Asia/Pacific (18.6%) and other (3.6%).
Employees
125,000
Date Price Change Volume
26-10-30 US$697.00 -1.72% 2,088,610
26-10-29 US$709.18 +0.71% 1,473,477
26-10-28 US$704.15 +1.61% 1,648,211
26-10-27 US$693.02 +1.19% 1,829,959
26-10-26 US$684.89 +1.64% 1,947,836
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Thermo Fisher Scientific, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
697.00USD
Average target price
752.12USD
Spread / Average Target
+7.91%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Thermo Fisher Scientific, Inc.